More detailed analysis of tumor growth in these mice showed that while EMT6siCD200 tumors were smaller than control EMT6 tumors, they had a greater percentage of CD45+ infiltrating immune cells (Fig 2A), suggesting an enhanced immune response in hosts bearing tumors with reduced CD200 expression. This evidence concerns the gene CD200 and neoplasm.